Dr. David Lowe explores how high-resolution HLA typing, virtual crossmatching, and emerging biomarker technologies are expanding transplant personalization, helping clinicians improve donor matching and monitor graft health.
Beyond the Match: Where Transplant Immunology Has Been and Where We Must Go
